Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -124,056 | -87,442 | -49,882 | 287,259 | 99,304 |
| Depreciation Amortization | 22,795 | 13,512 | 5,821 | 11,454 | 33,048 |
| Income taxes - deferred | 1,649 | 196 | -2,288 | 911 | 4,103 |
| Accounts receivable | 24,057 | 35,200 | 34,429 | -47,674 | -33,716 |
| Accounts payable and accrued liabilities | -10,970 | -14,939 | 411 | -16,343 | -18,764 |
| Other Working Capital | -87,444 | -57,614 | -1,946 | -168,801 | -180,447 |
| Other Operating Activity | 111,884 | 59,277 | 5,863 | 278,821 | 164,260 |
| Operating Cash Flow | $-62,085 | $-51,810 | $-7,592 | $345,627 | $67,788 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 120,802 | 5,889 | -85,023 | 5,008 | -152,126 |
| PPE Investments | -29,971 | -18,178 | -9,080 | -30,905 | -23,143 |
| Purchase Of Investment | N/A | N/A | N/A | -10,000 | N/A |
| Purchase Sale Intangibles | -4,203 | -3,023 | -904 | -5,377 | -4,196 |
| Other Investing Activity | -4,203 | -3,023 | -904 | -5,377 | -4,196 |
| Investing Cash Flow | $86,628 | $-15,312 | $-95,007 | $-41,274 | $-179,465 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 97,000 | N/A |
| Debt Repayment | N/A | 0 | N/A | -108,684 | -12,500 |
| Common Stock Issued | 29,450 | 16,453 | 7,652 | 175,767 | 112,137 |
| Common Stock Repurchased | -90,548 | -90,548 | -90,550 | -34,392 | 0 |
| Other Financing Activity | -14,031 | -11,971 | -11,603 | -29,670 | -18,841 |
| Financing Cash Flow | $-75,129 | $-86,066 | $-94,501 | $100,021 | $80,796 |
| Exchange Rate Effect | 358 | 82 | 8 | 93 | N/A |
| Beginning Cash Position | 683,287 | 683,287 | 683,287 | 278,820 | 278,820 |
| End Cash Position | 633,059 | 530,181 | 486,195 | 683,287 | 247,939 |
| Net Cash Flow | $-50,228 | $-153,106 | $-197,092 | $404,467 | $-30,881 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,085 | -51,810 | -7,592 | 345,627 | 67,788 |
| Capital Expenditure | -29,971 | -18,178 | -9,080 | -30,905 | -23,143 |
| Free Cash Flow | -92,056 | -69,988 | -16,672 | 314,722 | 44,645 |